{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:47:19Z","timestamp":1760014039751},"reference-count":89,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,12,8]],"date-time":"2006-12-08T00:00:00Z","timestamp":1165536000000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:p><jats:bold><jats:sc>Abstract:\u2002<\/jats:sc><\/jats:bold>  <jats:bold>Neuropathic pain is defined as pain caused by a lesion in the nervous system and is common in clinical practice. Diagnosis can be difficult. Recommendations for first\u2010line pharmacologic treatments are based on positive results from multiple, randomized, controlled trials, and recommendations for second\u2010line pharmacologic treatments are based on the positive result of a single, randomized, controlled trial or inconsistent results of multiple, randomized, controlled trials. The results of published trials and clinical experience provide the foundation for specific recommendations for first\u2010line treatments, which include gabapentin, 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants (TCAs). Gabapentin (up to 3,600 mg\/day) significantly reduced pain compared with placebo; improvements in sleep, mood, and quality of life were also demonstrated. Adverse effects of gababentin include somnolence and dizziness, and, less commonly, gastrointestinal symptoms and mild peripheral edema. Thus, monitoring and dosage adjustment are required, without discontinuation of the drug. Gabapentin combined with morphine achieved better analgesia at lower doses of each drug than each drug alone, with only mild adverse effects. The first medication that proved effective for neuropathic pain in placebo\u2010controlled trials was TCAs. Treatment decisions for patients with neuropathic pain can be difficult. Interest in the mechanisms and treatment of chronic neuropathic pain has increased during the past years, resulting in significant treatment advances in the future. In this article all recent knowledge on therapeutic management of chronic neuropathic pain is presented.<\/jats:bold> <\/jats:p>","DOI":"10.1196\/annals.1366.016","type":"journal-article","created":{"date-parts":[[2006,12,27]],"date-time":"2006-12-27T23:33:25Z","timestamp":1167262405000},"page":"164-186","source":"Crossref","is-referenced-by-count":44,"title":["Therapeutic Management of Chronic Neuropathic Pain"],"prefix":"10.1111","volume":"1088","author":[{"given":"ATHINA","family":"VADALOUCA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IOANNA","family":"SIAFAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ERIPHYLLI","family":"ARGYRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EVI","family":"VRACHNOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELENI","family":"MOKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,12,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200107000-00034"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.61.1.835"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5472.1765"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.23.1.777"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3959(98)00099-2","article-title":"Towards a mechanism based classification of pain?","volume":"77","author":"Woolf C.J.","year":"1998","journal-title":"Pain"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01307-0"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(03)00064-2"},{"key":"e_1_2_5_9_2","volume-title":"Classification of Chronic Pain","author":"Merskey H.","year":"1994"},{"key":"e_1_2_5_10_2","unstructured":"IASP (International Association for the Study of Pain).IASP pain terminology.http:\/\/www.halcyon.com\/iasp\/terms\u2010p.html."},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2004.00791.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.2001.0322"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.2001.0260"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.2001.0259"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a072498"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-9651(18)30801-5"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(93)90026-D"},{"key":"e_1_2_5_18_2","first-page":"879","volume-title":"Textbook of Pain","author":"Boivi J.","year":"1999"},{"key":"e_1_2_5_19_2","first-page":"13","volume-title":"Pain and Central Nervous System Disease: The Central Pain Syndromes","author":"Bonica J.J.","year":"1991"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)00144-4"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.12968\/hosp.2000.61.11.1459"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.64.12_suppl_3.S21"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.11.1524"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0300-x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3101161"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199712000-00010"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/NRE-2000-14103","article-title":"Neuropathic pain: review of mechanisms and pharmacologic management","volume":"14","author":"Ozra F.","year":"2000","journal-title":"Neurorehabilitation"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-87-8-370"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-996-0009-7"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90171-3"},{"key":"e_1_2_5_32_2","first-page":"34","article-title":"Cures heureuses de neuralgies facials essentielles par le diphenylhydantoinate de soude","volume":"63","author":"Bergouignan M.","year":"1942","journal-title":"Rev. Laryngol. Otol. Rhinol"},{"key":"e_1_2_5_33_2","article-title":"Symptomatic treatment of neuropathic pain: a focus on the role of anticonvulsants","author":"Beydoun A.","year":"2001","journal-title":"Medsc. CME Circle Lect"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1831"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.2.251"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1837"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00407-9"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/rapm.2002.35169"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200212000-00046"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2002.11753609"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-4-13"},{"key":"e_1_2_5_42_2","unstructured":"Moka E.et al.2004.The role of gabapentin as an add\u2010on therapy in chronic neuropathic pain [abstract].11th International Pain Clinic WSPC Tokyo Abstract Book:188."},{"key":"e_1_2_5_43_2","article-title":"Gabapentin for acute and chronic pain","volume":"3","author":"Wiffen P.J.","year":"2005","journal-title":"The Cohrane Database of Systematic Reviews"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00255-5"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.141"},{"key":"e_1_2_5_46_2","unstructured":"Moka E.et al.2004.The role of gabapentin in chronic neuropathic pain in MS patients: a 4\u2010year experience [abstract].2nd International Symposium of Regional Anaesthesia and Pain Therapy Chile ."},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00146-8"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00244-9"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00317-8"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.6.914"},{"key":"e_1_2_5_51_2","unstructured":"Argyra E.et al.2005.5% lidocaine patch in the treatment of neuropathic pain of diverse origin [abstract].Eur. J. Pall. Care\u2013Abstract book 9th Congress of the European Association for Palliative Care (EAPC):80."},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000057720.36503.2C"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00160-X"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1837"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00385-7"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.7.1015"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269216303pm815oa"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021420"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042580"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.24.3043"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra025411"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1842"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00079-2"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00020-4"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(03)00066-6"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006986824213"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1082-3174(11)80029-2"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(96)03140-5"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00154-2"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00301-0"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.505"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.2.184"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00484-5"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.11.2115"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216080-00004"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7012.1047"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055433.55136.55"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.05.001"},{"key":"e_1_2_5_79_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.7.915"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1583"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000058749.49264.BD"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.05.010"},{"key":"e_1_2_5_83_2","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.2001.0266"},{"key":"e_1_2_5_84_2","first-page":"A192","article-title":"Duloxetin at doses of 60 mgr QD and 60 mgr BID is effective in treatment of diabetic neuropathic pain (DNP)","volume":"62","author":"Wernicke J.F.","year":"2004","journal-title":"[abstract] Neurology"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1054\/jpai.2000.9435"},{"key":"e_1_2_5_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00189-9"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2002.38.2.668325"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.1089\/152091599317602"},{"key":"e_1_2_5_89_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/01.brs.0000149199.68381.fe","article-title":"Spinal cord stimulation for chronic low back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors","volume":"1","author":"Taylor R.S.","year":"2005","journal-title":"Spine"},{"key":"e_1_2_5_90_2","first-page":"1","article-title":"Algorithm for neuropathic pain treatment: an evidence\u2010based proposal","author":"Finnerup N.B.","year":"2005","journal-title":"Pain"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1366.016","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1366.016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T17:00:30Z","timestamp":1695661230000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1366.016"}},"subtitle":["An Examination of Pharmacologic Treatment"],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1196\/annals.1366.016"],"URL":"https:\/\/doi.org\/10.1196\/annals.1366.016","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}